<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自 News-Medical.Net - 来自世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-GB</language><item><title>研究表明葫芦巴碱可作为衰老过程中线粒体功能障碍的治疗剂</title><description>肌肉减少症是由于肌纤维消耗而导致的与年龄相关的骨骼肌衰退。</description><link/> https://www.news-medical.net/news/20240326/Study-reveals-trigonelline-as-a-therapeutic-agent-for-mitochondrial-dysfunction-in-aging.aspx<comments> https://www.news-medical.net/news/20240326/Study-reveals-trigonelline-as-a-therapeutic-agent-for-mitochondrial-dysfunction-in-aging.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=04e9c618-36aa-4a25-8c06-5c6f0bc3b419</guid><pubDate> Tue, 26 Mar 2024 10:34:00 -0400</pubDate> <media:content expression="full" height="1332" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_775540_17114635620183913.jpg" width="2000"><media:description><![CDATA[Study reveals trigonelline as a therapeutic agent for mitochondrial dysfunction in aging]]></media:description></media:content></item><item><title> Viroclinics-DDL 更名为 Cerba Research</title><description> Viroclinics-DDL 是一家世界领先的疫苗和抗病毒专业实验室，提供植根于病毒学的研究和临床试验解决方案，自豪地宣布自 2024 年 4 月 1 日起更名为 Cerba Research。</description><link/> https://www.news-medical.net/news/20240326/Viroclinics-DDL-changes-name-to-Cerba-Research.aspx<comments> https://www.news-medical.net/news/20240326/Viroclinics-DDL-changes-name-to-Cerba-Research.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=7fdb75a3-d6b7-48c5-be1d-37716a2da034</guid><pubDate> Tue, 26 Mar 2024 10:06:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2016/6/Chem_Lab_c618f8c3be2845828afd242b15eaaa94-620x480.jpg" width="620"><media:description><![CDATA[Viroclinics-DDL changes name to Cerba Research]]></media:description></media:content></item><item><title> Teva UK 和 Closed Loop Medicine 宣布建立战略合作伙伴关系，以推动个性化药物的开发</title><description>Teva UK Limited 和 Closed Loop Medicine Ltd 宣布建立战略合作伙伴关系，以推动个性化医疗的发展。</description><link/> https://www.news-medical.net/news/20240326/Teva-UK-and-Closed-Loop-Medicine-announce-strategic-partnership-to-advance-development-of-personalized-medicines.aspx<comments> https://www.news-medical.net/news/20240326/Teva-UK-and-Closed-Loop-Medicine-announce-strategic-partnership-to-advance-development-of-personalized-medicines.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=8a4acd58-18ef-48c1-b211-4de588ca50e7</guid><pubDate> Tue, 26 Mar 2024 09:58:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/6/Prescription_Drug-620x480.jpg" width="620"><media:description><![CDATA[Teva UK and Closed Loop Medicine announce strategic partnership to advance development of personalised medicines]]></media:description></media:content></item><item><title> Charpentier/Doudna CRISPR关键专利获中国国家知识产权局维持</title><description>RS Genomics Limited 的成立是为了提供对 Emmanuelle Charpentier 博士共同拥有的基础 CRISPR/Cas9 知识产权的广泛访问，今天宣布其专利 CN201380038920.6 获得 CNIPA 的支持，以应对无效挑战。</description><link/> https://www.news-medical.net/news/20240326/Key-CharpentierDoudna-CRISPR-patent-upheld-by-China-National-Intellectual-Property-Administration.aspx<comments> https://www.news-medical.net/news/20240326/Key-CharpentierDoudna-CRISPR-patent-upheld-by-China-National-Intellectual-Property-Administration.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=0b1a760a-c70d-4009-824f-97bab4d4e843</guid><pubDate> Tue, 26 Mar 2024 09:51:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2018/7/CRISPR_locus_on_DNA_sequence-Catalin_Rusnac_51742dddb09c41d2924841b1b4decc7a-620x480.jpg" width="620"><media:description><![CDATA[Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration]]></media:description></media:content></item><item><title> Ubiquigent 和 Debiopharm 达成协议，支持 Debio 0432 的 USP1 抑制剂项目</title><description>该项目将展示 Ubiquigent 以 DUB 为中心的平台如何支持 DUB 抑制剂从发现到临床开发的整个过程。</description><link/> https://www.news-medical.net/news/20240326/Ubiquigent-and-Debiopharm-enter-agreement-to-support-USP1-inhibitor-programme-for-Debio-0432.aspx<comments> https://www.news-medical.net/news/20240326/Ubiquigent-and-Debiopharm-enter-agreement-to-support-USP1-inhibitor-programme-for-Debio-0432.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=68d1aea4-3fe8-4d88-8fc6-e928fa2cbf48</guid><pubDate> Tue, 26 Mar 2024 09:48:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2019/5/Drug_use_and_prohibited_substances._-_Image_-_Monika_Gruszewicz_A1_b3acfd6d2daf44ecbd36979af20eb378-620x480.jpg" width="620"><media:description><![CDATA[Ubiquigent and Debiopharm enter agreement to support USP1 inhibitor programme for Debio 0432]]></media:description></media:content></item><item><title> Bio-Rad 推出用于稀有细胞和循环肿瘤细胞计数的经过验证的抗体</title><description>抗体经过验证可与 Bio-Rad 的 Celselect Slides™ 计数染色试剂盒一起使用，以便对液体活检样本中捕获的循环肿瘤细胞进行免疫染色。</description><link/> https://www.news-medical.net/news/20240326/Bio-Rad-launches-validated-antibodies-for-rare-cell-and-circulate-tumor-cell-enumeration.aspx<comments> https://www.news-medical.net/news/20240326/Bio-Rad-launches-validated-antibodies-for-rare-cell-and-circulate-tumor-cell-enumeration.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=8411a7c6-f073-41a0-b333-52c74e921b5c</guid><pubDate> Tue, 26 Mar 2024 09:44:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2018/7/antibody_in_pink_and_red_background_selective_focus_3d_art_-_Mirror-Images_A1_71b890c58eb74b42a6490cfe1b003dce-620x480.jpg" width="620"><media:description><![CDATA[Bio-Rad launches validated antibodies for rare cell and circulating tumor cell enumeration]]></media:description></media:content></item><item><title>化疗过量：一项常见的基因测试每年可以挽救数百人的生命</title><description>2021 年 1 月的一个早晨，卡罗尔·罗森 (Carol Rosen) 接受了转移性乳腺癌的标准治疗。可怕的三周后，她在剧烈的疼痛中死去，而这种药物本来可以延长她的生命。</description><link/> https://www.news-medical.net/news/20240326/Overdosing-on-chemo-A-common-gene-test-could-save-hundreds-of-lives-each-year.aspx<comments> https://www.news-medical.net/news/20240326/Overdosing-on-chemo-A-common-gene-test-could-save-hundreds-of-lives-each-year.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=7e2b4ed9-bd31-47cd-8707-7236a933a9ba</guid><pubDate> Tue, 26 Mar 2024 08:24:36 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Gene-620x480.jpg" width="620"><media:description><![CDATA[Overdosing on chemo: A common gene test could save hundreds of lives each year]]></media:description></media:content></item><item><title>研究发现，维生素 D 在针对衰老的生物机制方面显示出前景</title><description>目前已知维生素 D (VitD) 对调节某些衰老特征的潜在作用。</description><link/> https://www.news-medical.net/news/20240326/Vitamin-D-shows-promise-in-targeting-agings-biological-mechanisms-study-finds.aspx<comments> https://www.news-medical.net/news/20240326/Vitamin-D-shows-promise-in-targeting-agings-biological-mechanisms-study-finds.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=29210a3b-a1ff-4d18-b150-bb52de5e9f2c</guid><pubDate> Tue, 26 Mar 2024 07:37:00 -0400</pubDate> <media:content expression="full" height="1288" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_775508_17114529094844960.jpg" width="2000"><media:description><![CDATA[Vitamin D shows promise in targeting aging's biological mechanisms, study finds]]></media:description></media:content></item><item><title>尽管某些年龄组取得了进展，但全球抗击结核病的斗争未能达到 2020 年世界卫生组织的里程碑</title><description>全球、国家和区域结核病的负担和趋势。</description><link/> https://www.news-medical.net/news/20240326/Global-fight-against-TB-misses-2020-WHO-milestones-despite-progress-in-certain-age-groups.aspx<comments> https://www.news-medical.net/news/20240326/Global-fight-against-TB-misses-2020-WHO-milestones-despite-progress-in-certain-age-groups.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=0a348c6f-71cf-4918-ab1d-1f8c237bb64c</guid><pubDate> Tue, 26 Mar 2024 07:11:00 -0400</pubDate> <media:content expression="full" height="857" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_775504_17114513598223165.jpg" width="2000"><media:description><![CDATA[Global fight against TB misses 2020 WHO milestones, despite progress in certain age groups]]></media:description></media:content></item><item><title>综合研究显示全球总生育率自 1950 年以来减少了一半以上</title><description>对 1950 年至 2100 年 204 个国家和地区过去和未来生育率趋势的综合估计。</description><link/> https://www.news-medical.net/news/20240326/Compressive-study-reveals-global-total-fertility-rate-more-than-halved-since-1950.aspx<comments> https://www.news-medical.net/news/20240326/Compressive-study-reveals-global-total-fertility-rate-more-than-halved-since-1950.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=e866fa99-3292-499e-9ee3-dd0931e5c308</guid><pubDate> Tue, 26 Mar 2024 06:48:00 -0400</pubDate> <media:content expression="full" height="1332" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_775503_17114499781516993.jpg" width="2000"><media:description><![CDATA[Comprehensive study reveals global total fertility rate more than halved since 1950]]></media:description></media:content></item></channel></rss>